Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes

Archives of Ophthalmology

Volumn 115, Issue 7, 1997, Pages 857-861

  Linden, Christina ^a,c   Alm, Albert ^a,b,c  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Pharmacia & Upjohn AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; PHYSOSTIGMINE;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE ACTIVITY; AQUEOUS HUMOR OUTFLOW; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR HYPERTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0030742028     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160027004     Document Type: Article

References (36)

1. Camras CB, Bito LZ, Eakins KE. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest Ophthalmol Vis Sci. 1977:16:1125-1134.
2. Bito LZ, Draga A, Blanco J, Camras CB. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes. Invest Ophthalmol Vis Sci. 1983;24:312-319.
3. Lee P-Y, Podos SM, Severin C. Effect of prostaglandin FJa on aqueous humor dynamics of rabbit, cat, and monkey. Invest Ophthalmol Vis Sci. 1984:25:1087-1093.
4. Giuffrè G. The effects of prostaglandin F2a in the human eye. GraefesArch Clin Exp Ophthalmol. 1985:222:139-141.
5. Aim A, Villumsen J. PhXA34, a new potent ocular hypotensive drug: a study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol. 1991:109:1564-1568.
6. Aim A, Stjernschantz J, the Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology. 1995;102:1743-1752.
7. Watson P, Stjernschantz J, the Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology. 1996:103:126-137.
8. Camras CB, the United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a sixmonth, masked, multicenter trial in the United States. Ophthalmology. 1996: 103:138-147.
9. Crawford K, Kaufman PL. Pilocarpine antagonizes prostaglandin F2a-induced ocular hypotension in monkeys: evidence for enhancement of uveoscleral outflow by prostaglandin F2a. Arch Ophthalmol. 1987;105:1112-1116.
10. Crawford K, Kaufman PL, Gabelt BT. Effects of topical PGF2a on aqueous humor dynamics in cynomolgus monkeys. CurrEye Res. 1987:6:1035-1044.
11. 2α-1-isopropylester in the cynomolgus monkey. Exp fys fles 1989;48; 707 716.
12. Kerstetter JR. Brubaker RF, Wilson SE, Kullerstrand U. Prostaglandin F2 -1isopropylester lowers intraocular pressure without decreasing aqueous humor flow. Am J Ophthalmol. 1988;105:30-34.
13. 2α-isopropylester eye drops: effects in normal human eyes. Br J Ophthalmol. 1989:73:419-426.
14. α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol. 1993:111:1351-1358.
15. Toris CB, Camras CB, Yablonski ME. Effects of PhXA41, a new prostaglandin F2_ analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993;100: 1297-1304.
16. Bill A. The aqueous humor drainage mechanism in the cynomolgus monkey (Macaca irus) with evidence for unconventional routes. Invest Ophthalmol Vis Sci. 1965:4:911-919.
17. Bill A. Aqueous humor dynamics in monkeys (Macaca irus and Cercopithecus ethiops). Exp Eye Res. 1971 ;11:195-206.
18. Bill A, Wâlinder PE. The effects of pilocarpine on the dynamics of aqueous humor in a primate (Macaca irus). Invest Ophthalmol Vis Sci. 1966:5:170-175.
19. Bill A. Effects of atropine and pilocarpine on aqueous humour dynamics in cynomolgus monkeys (Macacairus). ExpEyeRes. 1967:6:120-125.
20. Bill A, Phillips CI. Uveoscleral drainage of aqueous humour in human eyes. Exp Eye Res. 1971:12:275-281.
21. 2α/piIocarpine interactions on IOP and accommodation in monkeys. ExpEyeRes. 1995:54:677-683.
22. 2α-Isopropylester and 17-Phenyl Substituted Analogues of Prostaglandin f2,Isopropylester. Urnea, Sweden: Urnea University Medical Dissertations; 1992. New Series publication 336-ISBN 91-7174-652-8, section 6.
23. Friström B, Nilsson SEG. Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine: a study on patients with elevated intraocular pressure. Arch Ophthalmol. 993;111:662-665.
24. Hogg RV, Ledolter J. Experiments with two or more factors. In: Engineering Statistics. New York, NY: Macmillan Publishing Co Inc; 1987:227-237.
25. 2α. Exp Eye Res. 1988:47:761-769.
26. Neider MW, Crawford K, Kaufman PL, Bito LZ. In vivo videography of the rhesus monkey accommodative apparatus: age-related loss of ciliary muscle response to central stimulation. Arch Ophthalmol. 1990:108:69-74.
27. Croft MA, Oyen MJ, Gange SJ, Fisher MR, Kaufman PL. Aging effects on accommodation and outflow facility responses to pilocarpine in humans. Arch Ophthalmol. 1996;114:586-592.
28. 2α analogue: effect on intraocular pressure in patients with ocular hypertension. Br J Ophthalmol. 1992;76:214-217.
29. 2α-isopropyl ester analogues for glaucoma treatment. Jpn J Ophthalmol. 1993:37:259-269.
30. The Pharmaceutical Society of Great Britain. In: Reynolds JEF, ed. Martindale: the Extra Pharmacopoeia. 31 st ed. London, England: The Pharmaceutical Society of Great Britain; 1993:1118-1119.
31. Krishna N, Leopold IH. The effect of BC-48 (demecarium bromide) on normal rabbit and human eyes. Am J Ophthalmol. 1960:49:270-277.
32. Drance SM, Carr F. Effects of phospholine-iodide (217MI) on intraocular pressure in man. Am J Ophthalmol. 1960;49:470-474.
33. Berggren L. Individual responsiveness to topical pilocarpine and the effects of variations in application technique. Acta Ophthalmol. 1985:63:642-646.
34. Ethier CR, Coloma FM, de Kater AW, Allingham RR. Retroperfusion studies of the aqueous outflow system, II: studies in human eyes. Invest Ophthalmol Vis Sci. 1995:36:2466-2475.
35. Mâepea O, Bill A. The pressures in the episcleral veins, Schlemm's canal and the trabecular meshwork in monkeys: effects of changes in intraocular pressure. Exp Eye Res. 1989:49:645-663.
36. Zeimer RC, Gieser DK, Wilensky JT, Noth JM, Mori MM, Odunukwe EE. A practical venomanometer: measurement of episcleral venous pressure and assessment of the normal range. Arch Ophthalmol. 1983:101:1447-1449.